Deciphera Pharmaceuticals, part of the ONO Group, is a biopharmaceutical company dedicated to discovering and developing innovative medicines for cancer patients. Utilizing its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology, Deciphera aims to improve patient lives through a broad portfolio of cutting-edge treatments.
The Director of Market Access Pricing & Analytics is a key leader within the US Market Access team, responsible for delivering insights that drive pricing, contracting, and reimbursement strategies.
Deciphera Pharmaceuticals, part of the ONO Group, is a biopharmaceutical company dedicated to discovering and developing innovative medicines for cancer patients. Utilizing its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology, Deciphera aims to improve patient lives through a broad portfolio of cutting-edge treatments.
Deciphera Pharmaceuticals